Click here for BBC news coverage
Drugs that target a specific type of retinoid acid receptor (RXR-γ) are a promising target to stimulate remyelination in the damaged central nervous system.
Click here for article by Huang and colleagues, Nature Neuroscience 2010;doi:10.1038/nn.2702